Related Experiment Video
Updated: May 4, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Myeloperoxidase upregulates endothelin receptor type B expression
Denise Lau1, Katalin Szöcs1, Anna Klinke2
1Cardiovascular Research Center, University Heart Center Hamburg, University Hospital Eppendorf, Martinistreet 52, 20246 Hamburg, Germany.
Myeloperoxidase (MPO) binding to vascular cells increases endothelin receptor type B (ETRB) expression via MAP kinase pathways. This enhances vasoconstriction, highlighting MPO
Area of Science:
- Vascular Biology
- Inflammation Research
- Enzymology
Background:
- Neutrophil activation releases myeloperoxidase (MPO), an enzyme involved in inflammation.
- MPO's role in reducing nitric oxide (NO) bioavailability is established, but its direct effects on vascular cells are less understood.
- Understanding MPO's interaction with endothelial and smooth muscle cells is crucial for comprehending vascular tone regulation.
Purpose of the Study:
- To investigate the functional consequences of MPO binding to endothelial and smooth muscle cells.
- To determine MPO's effect on endothelin receptor type B (ETRB) expression and vascular responsiveness.
- To elucidate the signaling pathways involved in MPO-mediated changes in vascular cells.
Main Methods:
- Exposure of cultured human umbilical vein endothelial cells (HUVECs) and human aortic smooth muscle cells (HAoSMCs) to MPO.
- Gene expression analysis using real-time PCR and Western blotting to assess ETRB and ETRA levels.
- Immunofluorescence staining to confirm protein localization.
- MAP kinase pathway inhibition studies (PD98059, SB203580).
- Ex vivo organ bath studies with MPO-incubated rat femoral artery sections.
Main Results:
- MPO significantly increased ETRB gene and protein expression in HUVECs and HAoSMCs.
- MPO's enzymatic activity was necessary for the upregulation of ETRB.
- MPO-induced ETRB expression in endothelial cells was mediated by MAP kinase pathways.
- MPO selectively increased ETRB expression in smooth muscle cells, leaving ETRA unchanged.
- Ex vivo studies showed increased ETRB agonist-dependent constriction in MPO-treated rat arteries.
Conclusions:
- MPO binding to endothelial and smooth muscle cells upregulates ETRB expression through MAP kinase signaling.
- MPO influences vascular tone not only by affecting NO bioavailability but also by increasing sensitivity to vasoconstrictors.
- These findings position MPO as a key regulator of vascular tone, originating from leukocytes.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Regulation of the Unfolded Protein Response

